221 results on '"Mönig, Stefan P."'
Search Results
2. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
3. Side Effects of Gastric Cancer Surgery: Prevention and Treatment
4. Assessment of predictors of early postoperative complications after primary robotically assisted Roux-en-Y gastric bypass: a multicenter, retrospective cohort study
5. Outcome of endoscopic vacuum therapy for duodenal perforation
6. Implementation and validation of a competency assessment tool for laparoscopic cholecystectomy
7. Studien der Arbeitsgruppe Magen-Ösophagus-Tumoren der Arbeitsgemeinschaft Internistische Onkologie (AIO)
8. Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score–Matched Analysis
9. Individualisierte Ösophaguschirurgie
10. Therapieoptionen beim oligometastasierten Magenkarzinom
11. Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The...
12. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
13. S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs: Version 2.0 – August 2019. AWMF-Registernummer: 032/009OL
14. Erratum to “Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue” [Eur J Surg Oncol 49 (5) (May 2023) 974–982]
15. Siewert Classification of Adenocarcinoma of the Esophagogastric Junction: Still In or Already Out?
16. RACE: Neoadjuvante Radiochemotherapie vs. Chemotherapie für Patienten mit lokal fortgeschrittenem, potenziell resektablem Adenokarzinom des ösophagogastralen Übergangs
17. Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature
18. International consensus on a complications list after gastrectomy for cancer
19. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
20. Multimodal treatment in locally advanced gastric cancer
21. Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue
22. Erratum to “Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue” [Eur J Surg Oncol 49 (5) (May 2023) 974–982]
23. Assessment of predictors of early postoperative complications after primary robotically assisted Roux-en-Y gastric bypass: a multicenter, retrospective cohort study
24. Outcome of endoscopic vacuum therapy for duodenal perforation
25. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival
26. Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
27. Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?
28. Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma
29. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
30. Multimodal treatment in oligometastatic gastric cancer
31. Homozygous GNAS 393C-Allele Carriers with Locally Advanced Esophageal Cancer Fail to Benefit from Platinum-Based Preoperative Chemoradiotherapy
32. Prognostic Significance of a New Grading System of Lymph Node Morphology After Neoadjuvant Radiochemotherapy for Esophageal Cancer
33. Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative).
34. Prognostic Relevance of Skip Metastases in Esophageal Cancer
35. Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Esophagus: ERCC1 Gene Polymorphisms for Prediction of Response and Prognosis
36. β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis
37. Influence of Neoadjuvant Chemoradiation on the Number and Size of Analyzed Lymph Nodes in Esophageal Cancer
38. Clinical Impact of MMP and TIMP Gene Polymorphisms in Gastric Cancer
39. Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy
40. Extracapsular Lymph Node Involvement Differs Between Squamous Cell and Adenocarcinoma of the Esophagus
41. Development and Validation of a Predictive Model for Internal Hernia After Roux-en-Y Gastric Bypass in a Multicentric Retrospective Cohort: The Swirl, Weight Excess Loss, Liquid Score.
42. Artificial Neural Network for Prediction of Lymph Node Metastases in Gastric Cancer: A Phase II Diagnostic Study
43. Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma
44. Vitamin intake and risk of subtypes of esophageal cancer in Germany
45. Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: Histomorphologic analysis
46. Differences between Biopsy- or Specimen-related Laurén andWorld Health Organization Classification in Gastric Cancer
47. Lesser curvature lymph node metastases with esophageal squamous cell carcinoma: Implications for gastroplasty
48. Current surgical treatment standards for esophageal and esophagogastric junction cancer
49. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression
50. Extracapsular lymph node spread: A new prognostic factor in gastric cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.